耐多药结核病的诊断、治疗和防治策略
侍效春;刘晓清;
摘要(Abstract)：
<正>耐多药(multidrug resistance,MDR)的定义是结核病患者感染的结核分枝杆菌经体外证实至少同时对异烟肼、利福平耐药。耐多药结核病(multidrug resistance tuberculosis,MDR-TB)包括原发性和获得性两种类型。原发性MDR-TB是由于耐多药结核杆菌的传播所引起的;而获得性MDR-TB是在治疗过程中出现的,这也是当前MDR-TB产生的主要
关键词(KeyWords)：
结核病;耐多药
基金项目(Foundation):
作者(Authors):
侍效春;刘晓清;
参考文献(References)：
- [1]World Health Organization.Global tuberculosis control.Epidemiology,strategy,financing[EB/OL].Genera:WHO,2009.http://www.who.int/en/.
- [2]World Health Organization.Multidrug and extensively drugresistant TB(M/XDR-TB):2010global report on surveillance and response[EB/OL].Genera:WHO,2010.http://www.who.int/en/.
- [3]Pandemic(H1N1)2009—update110[EB/OL].Geneva:World Health Organization.http://www.who.int/en/.
- [4]中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007—2008年)[R].北京:人民卫生出版社,2010.
- [5]Cho SN.Current issues on molecular and immunological diagnosis of tuberculosis[J].Yonsei Med J,2007,48:347359.
- [6]中国防痨协会.耐药结核病化学治疗指南(2009)[J].中华结核和呼吸杂志,2010,33:485-497.
- [7]Masjedi MR,Tabarsi P,Chitsaz E,et al.Outcome of treatment of MDR-TB patients with standardized regimens,lran,2002-2006[J].Int J Tuberc Lung Dis,2008,12:750755.
- [8]Leimane V,Riekstina V,Holtz TH,et al.Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia:a retrospective cohort study[J].Lancet,2005,365:318-326.
- [9]Andries K,Verhasselt P,Guillemont J,et al.A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis[J].Science,2005,307:223-227.
- [10]Lounis N,Veziris N,Chauffour A,et al.Combinations of R207910 with drugs used to treat multidrug—resistant tuberculosis have the potential to shorten treatment duration[J].Antimicrob Agents Chemother,2006,50:3543-3547.
- [11]Diacon AH,Pym A,Grobusch M,et al.The diarylquinoline TMC207 for multidrug-resistant Tuberculosis[J].N Engl J Med,2009,360:2397-2405.
- [12]Gandhi NR,Shah NS,Andrews JR,et a1.HIV infection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality[J].Am J Respir Crit Care Med,2010,181:80-86.
- [13]Keshavjee S,Farmer PE.Picking up the pace-scale-up of MDR tuberculosis treatment programs[J].N Engl J Med,2010,363:1781-1784.
- [14]Nathanson E,Nunn P,Uplekar M,et al.MDR tuberculosis-critical steps for prevention and control[J].N Engl J Med,2010,363:1050-1058.
- [15]Heller T,Lessells RJ,Wallrauch CG,et al.Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal South Africa[J].Int J Tuberc Lung Dis,2010,14:420-426.